Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel

Maurits G.L. Olthof, Diederik H.R. Kempen, Xifeng Liu, Mahrokh Dadsetan, Marianna A. Tryfonidou, Michael J Yaszemski, Wouter J.A. Dhert, Lichun Lu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The optimal release profile of locally delivered bone morphogenetic protein-2 (BMP-2) for safe and effective clinical application is unknown. In this work, the effect of differential BMP-2 release on bone formation was investigated using a novel biomaterial oligo[(polyethylene glycol) fumarate] bis[2-(methacryloyloxy) ethyl] phosphate hydrogel (OPF-BP) containing poly(lactic-co-glycolic acid) microspheres. Three composite implants with the same biomaterial chemistry and structure but different BMP-loading methods were created: BMP-2 encapsulated in microspheres (OPF-BP-Msp), BMP-2 encapsulated in microspheres and adsorbed on the phosphorylated hydrogel (OPF-BP-Cmb), and BMP-2 adsorbed on the phosphorylated hydrogel (OPF-BP-Ads). These composites were compared with the clinically used BMP-2 carrier, Infuse® absorbable collagen sponge (ACS). Differential release profiles of bioactive BMP-2 were achieved by these composites. In a rat subcutaneous implantation model, OPF-BP-Ads and ACS generated a large BMP-2 burst release (>75%), whereas a more sustained release was seen for OPF-BP-Msp and OPF-BP-Cmb (~25% and 50% burst, respectively). OPF-BP-Ads generated significantly more bone than did all other composites, and the bone formation was 12-fold higher than that of the clinically used ACS. Overall, this study clearly shows that BMP-2 burst release generates more subcutaneous bone than do sustained release in OPF-BP-microsphere composites. Furthermore, composites should not only function as a delivery vehicle but also provide a proper framework to achieve appropriate bone formation.

Original languageEnglish (US)
JournalJournal of Tissue Engineering and Regenerative Medicine
DOIs
StateAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Bone Morphogenetic Protein 2
Hydrogel
Osteogenesis
Hydrogels
Bone
Proteins
Microspheres
Composite materials
Porifera
Collagen
Biocompatible Materials
Bone and Bones
Biomaterials
Fumarates
Rats
Polyethylene glycols

Keywords

  • Biomaterials
  • Bone morphogenetic protein-2 release
  • Bone tissue engineering
  • Oligo[(polyethylene glycol) fumarate]
  • Poly(lactic-co-glycolic acid)

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel. / Olthof, Maurits G.L.; Kempen, Diederik H.R.; Liu, Xifeng; Dadsetan, Mahrokh; Tryfonidou, Marianna A.; Yaszemski, Michael J; Dhert, Wouter J.A.; Lu, Lichun.

In: Journal of Tissue Engineering and Regenerative Medicine, 01.01.2018.

Research output: Contribution to journalArticle

Olthof, Maurits G.L. ; Kempen, Diederik H.R. ; Liu, Xifeng ; Dadsetan, Mahrokh ; Tryfonidou, Marianna A. ; Yaszemski, Michael J ; Dhert, Wouter J.A. ; Lu, Lichun. / Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel. In: Journal of Tissue Engineering and Regenerative Medicine. 2018.
@article{92bd91464a094648af9e21562b9c5d2b,
title = "Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel",
abstract = "The optimal release profile of locally delivered bone morphogenetic protein-2 (BMP-2) for safe and effective clinical application is unknown. In this work, the effect of differential BMP-2 release on bone formation was investigated using a novel biomaterial oligo[(polyethylene glycol) fumarate] bis[2-(methacryloyloxy) ethyl] phosphate hydrogel (OPF-BP) containing poly(lactic-co-glycolic acid) microspheres. Three composite implants with the same biomaterial chemistry and structure but different BMP-loading methods were created: BMP-2 encapsulated in microspheres (OPF-BP-Msp), BMP-2 encapsulated in microspheres and adsorbed on the phosphorylated hydrogel (OPF-BP-Cmb), and BMP-2 adsorbed on the phosphorylated hydrogel (OPF-BP-Ads). These composites were compared with the clinically used BMP-2 carrier, Infuse{\circledR} absorbable collagen sponge (ACS). Differential release profiles of bioactive BMP-2 were achieved by these composites. In a rat subcutaneous implantation model, OPF-BP-Ads and ACS generated a large BMP-2 burst release (>75{\%}), whereas a more sustained release was seen for OPF-BP-Msp and OPF-BP-Cmb (~25{\%} and 50{\%} burst, respectively). OPF-BP-Ads generated significantly more bone than did all other composites, and the bone formation was 12-fold higher than that of the clinically used ACS. Overall, this study clearly shows that BMP-2 burst release generates more subcutaneous bone than do sustained release in OPF-BP-microsphere composites. Furthermore, composites should not only function as a delivery vehicle but also provide a proper framework to achieve appropriate bone formation.",
keywords = "Biomaterials, Bone morphogenetic protein-2 release, Bone tissue engineering, Oligo[(polyethylene glycol) fumarate], Poly(lactic-co-glycolic acid)",
author = "Olthof, {Maurits G.L.} and Kempen, {Diederik H.R.} and Xifeng Liu and Mahrokh Dadsetan and Tryfonidou, {Marianna A.} and Yaszemski, {Michael J} and Dhert, {Wouter J.A.} and Lichun Lu",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/term.2664",
language = "English (US)",
journal = "Journal of Tissue Engineering and Regenerative Medicine",
issn = "1932-6254",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel

AU - Olthof, Maurits G.L.

AU - Kempen, Diederik H.R.

AU - Liu, Xifeng

AU - Dadsetan, Mahrokh

AU - Tryfonidou, Marianna A.

AU - Yaszemski, Michael J

AU - Dhert, Wouter J.A.

AU - Lu, Lichun

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The optimal release profile of locally delivered bone morphogenetic protein-2 (BMP-2) for safe and effective clinical application is unknown. In this work, the effect of differential BMP-2 release on bone formation was investigated using a novel biomaterial oligo[(polyethylene glycol) fumarate] bis[2-(methacryloyloxy) ethyl] phosphate hydrogel (OPF-BP) containing poly(lactic-co-glycolic acid) microspheres. Three composite implants with the same biomaterial chemistry and structure but different BMP-loading methods were created: BMP-2 encapsulated in microspheres (OPF-BP-Msp), BMP-2 encapsulated in microspheres and adsorbed on the phosphorylated hydrogel (OPF-BP-Cmb), and BMP-2 adsorbed on the phosphorylated hydrogel (OPF-BP-Ads). These composites were compared with the clinically used BMP-2 carrier, Infuse® absorbable collagen sponge (ACS). Differential release profiles of bioactive BMP-2 were achieved by these composites. In a rat subcutaneous implantation model, OPF-BP-Ads and ACS generated a large BMP-2 burst release (>75%), whereas a more sustained release was seen for OPF-BP-Msp and OPF-BP-Cmb (~25% and 50% burst, respectively). OPF-BP-Ads generated significantly more bone than did all other composites, and the bone formation was 12-fold higher than that of the clinically used ACS. Overall, this study clearly shows that BMP-2 burst release generates more subcutaneous bone than do sustained release in OPF-BP-microsphere composites. Furthermore, composites should not only function as a delivery vehicle but also provide a proper framework to achieve appropriate bone formation.

AB - The optimal release profile of locally delivered bone morphogenetic protein-2 (BMP-2) for safe and effective clinical application is unknown. In this work, the effect of differential BMP-2 release on bone formation was investigated using a novel biomaterial oligo[(polyethylene glycol) fumarate] bis[2-(methacryloyloxy) ethyl] phosphate hydrogel (OPF-BP) containing poly(lactic-co-glycolic acid) microspheres. Three composite implants with the same biomaterial chemistry and structure but different BMP-loading methods were created: BMP-2 encapsulated in microspheres (OPF-BP-Msp), BMP-2 encapsulated in microspheres and adsorbed on the phosphorylated hydrogel (OPF-BP-Cmb), and BMP-2 adsorbed on the phosphorylated hydrogel (OPF-BP-Ads). These composites were compared with the clinically used BMP-2 carrier, Infuse® absorbable collagen sponge (ACS). Differential release profiles of bioactive BMP-2 were achieved by these composites. In a rat subcutaneous implantation model, OPF-BP-Ads and ACS generated a large BMP-2 burst release (>75%), whereas a more sustained release was seen for OPF-BP-Msp and OPF-BP-Cmb (~25% and 50% burst, respectively). OPF-BP-Ads generated significantly more bone than did all other composites, and the bone formation was 12-fold higher than that of the clinically used ACS. Overall, this study clearly shows that BMP-2 burst release generates more subcutaneous bone than do sustained release in OPF-BP-microsphere composites. Furthermore, composites should not only function as a delivery vehicle but also provide a proper framework to achieve appropriate bone formation.

KW - Biomaterials

KW - Bone morphogenetic protein-2 release

KW - Bone tissue engineering

KW - Oligo[(polyethylene glycol) fumarate]

KW - Poly(lactic-co-glycolic acid)

UR - http://www.scopus.com/inward/record.url?scp=85046159086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046159086&partnerID=8YFLogxK

U2 - 10.1002/term.2664

DO - 10.1002/term.2664

M3 - Article

C2 - 29603878

AN - SCOPUS:85046159086

JO - Journal of Tissue Engineering and Regenerative Medicine

JF - Journal of Tissue Engineering and Regenerative Medicine

SN - 1932-6254

ER -